相关实验视频
Updated: Jun 26, 2026
10:05
High-throughput Detection Method for Influenza Virus
Published on: February 4, 2012
26.7K
发现了强大而有效的流感PB2抑制剂
Jun Wu1, Yongfu Liu1, Dongbo Li1
1Medicinal Chemistry, China Innovation Center of Roche, Shanghai 201203, China.
ACS medicinal chemistry letters
|January 14, 2026
概括
研究人员通过修改pimodivir.开发了一个新的流感药物候选物,化合物3,通过修改pimodivir. 这种新型抑制剂显示出更好的效能和药理动力学特性,为流感治疗提供了一个有前途的替代方案.
科学领域:
- 药用化学 医学化学
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 流感病毒对全球健康构成重大威胁.
- 现有的抗病毒疗法面临着抗药性和副作用等挑战.
- PB2 抑制剂代表了一类有前途的流感抗病毒药物.
研究的目的:
- 设计和合成新型流感PB2抑制剂,以改善代谢稳定性和药物动力学特征.
- 评估一种新化合物对抗流感病毒的抗病毒功效和有效性.
- 为了将新型抑制剂与已知的PB2抑制剂比较,pimodivir.
主要方法:
- 皮莫迪维尔基架的化学修改,将7-azaindole核心替换为7替代的英达.
- 引入一个循环烯合环到bicyclo[2.2.2]-octane部分.
- 复合物3的体外和体内评估,包括药理动力学研究和致命流感小鼠挑战模型.
主要成果:
- 化合物3通过减轻CYP3A和阿尔德海德氧化酶介导的代谢,证明了增强的代谢稳定性.
- 新的英达支架和合的环环协同改善了功效和药理动力学特性.
- 在致命的流感小鼠模型中,化合物3与皮莫迪维尔相比,有效剂量减少了7倍,并改善了对流感A菌株的活性.
结论:
- 化合物3是一种强效的流感PB2抑制剂,具有差异化的作用机制.
- 结构修改成功地解决了代谢负债,并改善了整体类似药物的特性.
- 化合物3具有作为下一代流感感染抗病毒疗法的巨大潜力.
更多相关视频
22:10Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
13.7K
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
19.0K
相关概念视频
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...